Scinai Immunotherapeutics Ltd SCNI
$3.22 $0.28 (9.52%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
SCNI Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Scinai Immunotherapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Scinai Immunotherapeutics Ltd. Stock Analysis SCNI
United States Health Care Nano Cap Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Scinai Immunotherapeutics Ltd (SCNI) Chart
Financial Metrics & Statements of Scinai Immunotherapeutics Ltd (SCNI)
FAQ's for Scinai Immunotherapeutics Ltd (SCNI)
- As of August 2026, Scinai Immunotherapeutics Ltd SCNI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Scinai Immunotherapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Scinai Immunotherapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Scinai Immunotherapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Scinai Immunotherapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Scinai Immunotherapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Scinai Immunotherapeutics Ltd (SCNI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
